𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Differences in induction of hepatic cytochrome p450 isozymes by mice in eight methylenedioxyphenyl compounds

✍ Scribed by Lewandowski, Margaret ;Chui, Y. C. ;Levi, Patricia E. ;Hodgson, Ernest


Publisher
John Wiley and Sons
Year
1990
Tongue
English
Weight
900 KB
Volume
5
Category
Article
ISSN
0887-2082

No coin nor oath required. For personal study only.

✦ Synopsis


Eight methylenedioxyphenyl (MDP) compounds were examined for their ability to induce cytochrome P450 (P450) in mouse liver. Induction by safrole, isosafrole, and dihydrosafrole was studied in both C57BLl6N (Ah-responsive) and DBA/2N (Ahnonresponsive) male mice after IP administration of 200 mglkglday MDP compound for 3 days. Hepatic P450 content, ethylmorphine N-demethylase, ethoxyresorufin 0-deethylase, and acetanilide hydroxylase activities were induced to the same extent in both strains of mice. Benzo(a)pyrene hydroxylase activity, however, was not induced in either C57 or DBA mice. The similarity of results in both strains of mice indicated induction of these P450 isozymes by these three MDP compounds is not mediated by the Ah receptor. Induction of P450 by butylbenzodioxole (n- butyl-BD), tertiarybutylbenzodioxole (t-butyl-BD), methylbenzodioxole (methyl-BD), nitrobenzodioxole (nitro-BD), and bromobenzodioxole (bromo-BD) was examined only in C57BL/6N mice. Methyl-BD, nitro-BD, and bromo-BD did not induce hepatic micro-soma1 proteins or selected P450 monooxygenase activities. In contrast, n-butyl-BD, and t-butyl-BD induced P450 content, ethylmorphine N-demethylase, acetanilide hydroxylase, and ethoxyresorufin O-deethylase activities. Benzo(a)pyrene hydroxylase was not induced by any of the treatments. Induction of these P450 activities is consistent with induction of P450 IIBl and P450 IA2, but not induction of P450 IA1. Western blot analysis with antibodies to P450 isozymes induced with either phenobarbital (Pb) or 3-


πŸ“œ SIMILAR VOLUMES


Species differences in ciprofibrate indu
✍ Makowska, Janet M. ;Gibson, G. Gordon ;Banner, Frank W. πŸ“‚ Article πŸ“… 1992 πŸ› John Wiley and Sons 🌐 English βš– 849 KB

Six species (CD-1 mouse, Fischer 344 rat, Syrian golden hamster, Duncan-Hartley guinea pig, half-lop rabbit and marmoset monkey) were treated orally with ciprofibrate, a potent oxyisobutyrate hypolipidaemic drug for 14 days. A dosedependent liver enlargement was observed in the mouse and rat and at

Induction of specific cytochrome P450s i
✍ Gordon M. Kirby; Isabelle Chemin; Ruggero Montesano; Francis V. Chisari; Matti A πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 772 KB

## Abstract The relative roles of hepatitis B virus (HBV) and aflatoxn and their possible mechanism of interaction in the etiopathogenesis of hepatocellular carcinoma (HCC) are not understood. One hypothesis is that viral infection and associated liver injury alter expression of carcinogen‐metaboli

Investigation of hepatic cytochrome P-45
✍ Christine C. Hedli; Robert Snyder; Florence K. Kinoshita; Marshall Steinberg πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 82 KB

## Exposure of experimental animals to toxaphene induces hepatic cytochrome P-450 (CYP). Although chronic administration of toxaphene to mice was found to cause an increased incidence of liver tumors, a mechanism for its carcinogenicity has yet to be elucidated. We investigated two potential mecha

Induction of cytochrome P450 2E1 increas
✍ Xiaodong Wang; Yongke Lu; Arthur I. Cederbaum πŸ“‚ Article πŸ“… 2005 πŸ› John Wiley and Sons 🌐 English βš– 511 KB

Cytochrome P450 2E1 (CYP2E1) may be a central pathway in generating oxidative stress, reactive oxygen species, and causing hepatotoxic injury by alcohol and various hepatotoxins. This study evaluated the ability of CYP2E1 to potentiate or synergize the hepatotoxicity of Fas in vivo. C57BL/6 mice wer